INS and metabolic dysfunction-associated steatotic liver disease: MASLD involves multiple pathways of liver metabolic abnormalities, including lipid metabolism disorders, insulin signaling defects, inflammatory responses, and enhanced oxidative stress, which are interrelated and collectively promote the occurrence and development of MASLD.18